Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Anicura Gistrup Dyrehospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.1% 1.1% 1.3% 3.9% 3.0% 1.2% 11.6% 11.6%   Credit score (0-100)   86 85 83 52 57 82 20 19   Credit rating   A A A BBB BBB A BB BB   Credit limit (kDKK)   351.9 270.2 56.2 0.0 0.0 115.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,895 4,974 5,142 4,515 4,300 6,333 0.0 0.0   EBITDA   1,022 1,205 1,094 500 437 1,200 0.0 0.0   EBIT   612 636 485 -181 10.6 821 0.0 0.0   Pre-tax profit (PTP)   662.0 723.2 537.9 -168.3 26.1 839.8 0.0 0.0   Net earnings   515.0 563.8 418.4 -131.3 20.2 655.2 0.0 0.0   Pre-tax profit without non-rec. items   662 723 538 -168 26.1 840 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   1,530 1,396 1,025 1,075 977 755 0.0 0.0   Shareholders equity total   5,834 6,397 1,816 1,684 1,705 2,360 2,235 2,235   Interest-bearing liabilities   357 55.8 134 166 264 86.8 0.0 0.0   Balance sheet total (assets)   7,667 8,051 3,350 3,101 3,925 3,726 2,235 2,235   Net Debt   -1,860 -578 21.4 -207 254 69.9 -2,235 -2,235     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,895 4,974 5,142 4,515 4,300 6,333 0.0 0.0   Gross profit growth   0.0% 1.6% 3.4% -12.2% -4.8% 47.3% -100.0% 0.0%   Employees   9 10 10 11 9 9 0 0   Employee growth %   0.0% 11.1% 0.0% 10.0% -18.2% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,667 8,051 3,350 3,101 3,925 3,726 2,235 2,235   Balance sheet change%   0.0% 5.0% -58.4% -7.4% 26.6% -5.1% -40.0% 0.0%   Added value   612.0 636.5 484.5 -181.3 10.6 821.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,777 -922 -1,198 -851 -524 -600 -755 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.5% 12.8% 9.4% -4.0% 0.2% 13.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.6% 9.3% 9.6% -5.1% 0.7% 22.0% 0.0% 0.0%   ROI %   10.4% 11.3% 12.6% -8.2% 1.2% 35.3% 0.0% 0.0%   ROE %   8.8% 9.2% 10.2% -7.5% 1.2% 32.2% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   76.1% 79.5% 54.2% 54.3% 43.4% 63.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -182.0% -48.0% 2.0% -41.5% 58.2% 5.8% 0.0% 0.0%   Gearing %   6.1% 0.9% 7.4% 9.9% 15.5% 3.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.5% 8.9% 1.5% 0.0% 0.9% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   3.0 3.8 1.1 1.2 1.4 1.9 0.0 0.0   Current Ratio   3.3 4.1 1.5 1.6 1.6 2.2 0.0 0.0   Cash and cash equivalent   2,217.0 634.2 113.1 373.8 10.1 16.9 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,838.0 4,717.2 654.2 755.7 1,082.2 1,604.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   68 64 48 -16 1 91 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   114 121 109 45 49 133 0 0   EBIT / employee   68 64 48 -16 1 91 0 0   Net earnings / employee   57 56 42 -12 2 73 0 0